Selectivity rises, prepared firms pull ahead
The first quarter of 2026 (Q1’26) opened with an apparent contradiction: Deal teams showed greater confidence but executed fewer transactions. Financial services mergers and acquisitions (M&A) in Q1’26 suggest that the market has largely found its direction, even as participants adjust to a more measured pace. In US banking, early-quarter results showed how a small number of large deals can drive total announced value even when the number of deals remains modest.1 Total value fell from the unusually strong fourth quarter of 2025 (Q4’25), when a few transformational deals boosted the figures, and activity normalized after the year-end surge. This looks less like a pullback and more like a pause to absorb and integrate recent moves.
This quarter’s story is less about speed and more about being selective in a clearer rulebook. In US banking, regulatory approval timelines continue to shorten, which can heighten execution risk.2 Legal and advisory commentary also points to a more predictable, supportive environment, and emphasizes that being ready to execute is increasingly a differentiator.3 As a result, management teams are approaching deals differently, with fewer exploratory efforts and more well-supported scale transactions with clear, measurable operating benefits. Buyers are engaging more selectively and committing later, but when they engage, they move with conviction and impose tighter execution standards. Tighter credit markets resulting from geopolitical uncertainty may affect the volume and size of deals.
Across subsectors, the pressures are not the same. Banks—especially smaller ones—have a shrinking window to “make scale pay off.” Banks are acquiring or partnering with fintechs to modernize, but face infrastructure and technology integration struggles. Capital markets firms are still using consolidation, not organic growth, to fund investment—especially where distribution and operating leverage reinforce each other. Insurance remains split: Activity is stronger when a deal adds distribution control or a specialty capability, and more limited elsewhere due to underwriting volatility and tighter valuation discipline. This quarter, the main challenges were less about macro uncertainty and more about execution realism. Technology integration, data migration, control environments, and regulatory readiness are now core diligence priorities—not items to address after signing.
Three themes stood out this quarter:
- First, financing and structure: Deal value was driven largely by all-stock or mixed-consideration transactions. This reflects the preference of many management teams to protect balance sheets and reduce exposure to interest-rate moves.
- Second, concentrated value versus dispersed volume: Total announced value is still shaped by a small number of large deals—especially in banking and capital markets. Because of that, deal count alone can make the market look healthier than it is if the mix of deals is not considered.
- Third, integration reality: Buyers are treating post-close execution as a make-or-break factor, not a later workstream. If technology, risk, or compliance integration cannot be credibly sequenced within 12 to 18 months, then deals tend to slow down, reprice, or stop.
We would be remiss if we did not note that GenAI is fundamentally changing due diligence, planning, and execution. Injecting safe and locked down GenAI into a deal changes diligence and integration from a retrospective, sample-based process into a full-coverage, intelligence-led engine that not only identifies risk but quantifies value at a process, contract, and data level. The real shift isn’t speed, it’s that by the time the deal is signed, buyers can already have a bottom-up transformation roadmap and can start executing value from Day 1.
The watch-out is simple: Faster approvals shorten the time between signing and realizing value. Acquirers that wait until after the announcement to plan integration may miss the window to capture the benefits this cycle can offer.
